Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for '500 Fulvestrant'

500 Fulvestrant published presentations and documents on DocSlides.

Her-2 negative MBC

Her-2 negative MBC

  • conchita-marotz
  • 47 Slides

10/25/2016. Objectives. General principles. Endoc...

Hormone Receptor-Positive Advanced Breast Cancer:

Hormone Receptor-Positive Advanced Breast Cancer:

  • min-jolicoeur
  • 0 Slides

HR Advanced Breast Cancer:. Introduction. Case S...

The Nurse View: Hormone Receptor-Positive Advanced Breast Cancer

The Nurse View: Hormone Receptor-Positive Advanced Breast Cancer

  • min-jolicoeur
  • 0 Slides

HR Advanced Breast Cancer. Introduction. Restagi...

BELLE-3: A Phase III Study of

BELLE-3: A Phase III Study of

  • faustina-dinatale
  • 0 Slides

Buparlisib. and . Fulvestrant. in Postmenopausa...

Jointly provided by & This activity is supported by educations grants from Novartis Pharmaceuticals Corporation, Pfizer, and Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com

Jointly provided by & This activity is supported by educations grants from Novartis Pharmaceuticals Corporation, Pfizer, and Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com

  • olivia-moreira
  • 67 Slides

Jointly provided by ...

Targeting endocrine-resistance pathways in breast cancer

Targeting endocrine-resistance pathways in breast cancer

  • alexa-scheidler
  • 48 Slides

Targeting endocrine-resistance pathways in breas...

Hormone Receptor Positive Metastatic Breast Cancer

Hormone Receptor Positive Metastatic Breast Cancer

  • pamella-moone
  • 80 Slides

. 5/9/2017. The Lancet July 11, 1895. ON THE TRE...

Endocrine Treatment of Metastatic Breast Cancer: New Advances; Patient Education Implications

Endocrine Treatment of Metastatic Breast Cancer: New Advances; Patient Education Implications

  • calandra-battersby
  • 74 Slides

An Interactive Oncology Grand Rounds Series. Joyc...

PrECOG 0102: A Randomized, Double-Blind Phase II Trial of Fulvestrant plus Everolimus or Placebo

PrECOG 0102: A Randomized, Double-Blind Phase II Trial of Fulvestrant plus Everolimus or Placebo

  • tawny-fly
  • 7 Slides

Post-Menopausal Women with Hormone-Receptor Posit...

Endocrine resistance: molecular pathways and rational development of targeted therapies

Endocrine resistance: molecular pathways and rational development of targeted therapies

  • spottletoefacebook
  • 66 Slides

Grazia Arpino. Università di Napoli Federico II. ...

CDK4-6 INHIBITORS IN Breast Cancer: Optimal Treatment Sequencing

CDK4-6 INHIBITORS IN Breast Cancer: Optimal Treatment Sequencing

  • leah
  • 28 Slides

Mansoor A Khan, BS, MS, BCOP. Oncology/Hematology/...

Fulvestrant 500 mg versus

Fulvestrant 500 mg versus

  • elena
  • 30 Slides

anastrozole. as first-line treatment for advanced...

Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor

Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor

  • byrne
  • 18 Slides

Overall survival and updated progression-free surv...

Module 8: ER-Positive Metastatic

Module 8: ER-Positive Metastatic

  • anastasia
  • 50 Slides

Breast Cancer . Elizabeth O’Reilly, MSN, MPH, AN...

Copyright © 2024 DocSlides. All Rights Reserved